Current treatment options in uterine endometrial stromal sarcoma: Report of a case and review of the literature

International Journal of Gynecological Cancer

Volumn 17, Issue 5, 2007, Pages 957-963

  Ihnen, M ^a   Mahner, S ^a   Janicke F ^a   Schwarz, J ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Advanced endometrial stromal sarcoma; Chemotherapy; Endocrine therapy; Radiotherapy; Surgery

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IFOSFAMIDE; TAMOXIFEN;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CASE REPORT; CYSTECTOMY; DIARRHEA; ENDOMETRIUM; ENDOMETRIUM SARCOMA; FEMALE; HUMAN; MULTIPLE CYCLE TREATMENT; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; SOMNOLENCE; TREATMENT OUTCOME; UTERUS SARCOMA; VAGINAL HYSTERECTOMY; VOMITING;

EID: 34548698693     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00889.x     Document Type: Article

References (41)

1. Platz CE, Benda JA. Female genital tract cancer. Cancer 1995 75 : 270 94.
2. Reich O, Regauer S. Endometrial stromal sarcoma-observational evidence of a genetic background? Eur J Gynaecol Oncol 2005 26 : 288 90.
3. Gynecologic Oncology Group. Available at : http://www.gog.org. Accessed May 10, 2005.
4. Shepherd JH. Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 1989 96 : 889 92.
5. Norris HJ, Taylor HB. Mesenchymal tumors of the uterus. I. A clinical and pathologic study of 53 endometrial stromal tumors. Cancer 1966 19 : 755 66.
6. Pautier P, Genestie C, Rey A et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft-tissue sarcoma. Cancer 2000 88 : 1425 31.
7. Zoloudek C, Hendrickson MR. Mesenchymal tumors of the uterus. In : Kurman RJ, ed. Blustein's pathology of the female genital tract, 5th edn. New York, NY : Springer, 2002 : 561 615.
8. Inayama Y, Shoji A, Odagiri S et al. Detection of pulmonary metastasis of low-grade endometrial stromal sarcoma 25 years after hysterectomy. Pathol Res Pract 2000 196 : 129 34.
9. Chang KL, Crabtree GS, Lim-Tan SK et al. Primary endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 1990 14 : 415 38.
10. Kanjeekal S, Chambers A, Fung MF et al. Systemic therapy for advanced uterine sarcoma: a systematic review of the literature. Gynecol Oncol 2005 97 : 624 37.
11. Sagae S, Yamashita K, Ishioka S et al. Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan. Oncology 2004 67 : 33 9.
12. Gadducci A, Romanini A. Adjuvant chemotherapy in early stage uterine sarcomas: an open question. Eur J Gynaecol Oncol 2001 22 : 352 7.
13. The National Cancer Institute. Available at : http://www.Cancer.gov/ cancertopics/pdq/treatment/uterinesarcoma/HealthProfessional. Accessed Dec 19, 2006.
14. Nordal RR, Kristensen GB, Kaern J et al. The prognostic significance of surgery, tumor size, malignancy grade menopausal status, and DNA ploidy in endometrial stromal sarcoma. Gynecol Oncol 1996 62 : 254 9.
15. Reich O, Regauer S, Winter R. Should lymphadenectomy be performed in patients with endometrial stromal sarcoma? Gynecol Oncol 2005 97 : 982 6.
16. Goff BA, Rice LW, Fleischhacker D et al. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol 1993 50 : 105 9.
17. Riopel J, Plante M, Renaud MC et al. Lymph node metastases in low-grade endometrial stromal sarcoma. Gynecol Oncol 2005 96 : 402 6.
18. Benoit L, Arnould L, Cheynel N et al. The role of surgery and treatment trends in uterine sarcoma. Eur J Surg Oncol 2005 31 : 434 42.
19. Giuntoli RL, Metzinger DS, DiMarco CS et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management and adjuvant therapy. Gynecol Oncol 2003 89 : 460 9.
20. Knocke TH, Kucera H, Dorfler D et al. Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri. Cancer 1998 83 : 1972 9.
21. Reed NS, Mangioni C, Malmstrom H et al. First results of a randomized trial comparing radiotherapy vs observation postoperatively in patients with uterine sarcomas. An EORTC GCG Study [abstract]. Int J Gynecol Cancer 2003 13 (Suppl. 1 4. Abstract PL12.
22. The National Comprehensive Cancer Network. Practice guidelines in oncology uterine sarcoma, v. 2, 2006. Available at : http://www.nccn.org/ professionals/physician_gls/default.asp. Accessed Aug. 5, 2006.
23. Available at : http://www.utdol.com/utd/content/topic.do?topicKey= gyne_onc/13917&type=A&selectedTitle=2∼8.
24. Weitmann HD, Knocke TH, Kucera H et al. Radiation therapy in the treatment of endometrial stromalsarcoma. Int J Radiat Oncol Biol Phys 2001 49 : 739 48.
25. Omura GA, Blessing JA, Major F et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. J Clin Oncol 1985 3 : 1240 5.
26. Omura GA, Major FJ, Blessing JA et al. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 1983 52 : 626 32.
27. Muss HB, Bundy B, DiSaia PJ et al. Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group). Cancer 1985 55 : 1648 53.
28. Sutton G, Brunetto VL, Kilgore L et al. A phase II trial of ifosfamide with or without cisplatin in carcinosaroma of the uterus: a Gynecologic Oncology Group Study. Gynecol Oncol 2000 79 : 147 53.
29. Berchuck A, Rubin SC, Hoskins WJ et al. Treatment of endometrial stromal tumors. Gynecol Oncol 1990 36 : 60 5.
30. Sutton G, Blessing JA, Park R et al. Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group. Obstet Gynecol 1996 87 : 747 50.
31. Szlosarek PW, Lofts FJ, Pettengell R et al. Effective treatment of a patient with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel. Anticancer Drugs 2000 11 : 275 8.
32. Yamawaki T, Shimizu Y, Hasumi K. Treatment of stage IV "high-grade" endometrial stromal sarcoma with ifosfamide, adriamycin, and cisplatin. Gynecol Oncol 1997 64 : 265 9.
33. Lin YC, Kudelka AP, Tresukosol D et al. Prolonged stabilization of progressive endometrial stromal sarcoma with prolonged oral etoposide therapy. Gynecol Oncol 1995 58 : 262 5.
34. Jensen PA, Dockerty MB, Symmonds RE et al. Endometroid sarcoma ("stromal endometriosis"): report of 15 cases including 5 with metastases. Am J Obstet Gynecol 1966 95 : 79 90.
35. Nordal RR, Thoresen SO. Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality. Eur J Cancer 1997 33 : 907 11.
36. Scribner DR Jr., Walker JL. Low-grade endometrial stromal sarcoma preoperative treatment with depo-lupron and megace. Gynecol Oncol 1998 71 : 458 60.
37. Pink D, Lindner T, Mrozek A et al. Harn or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature. Gynecol Oncol 2006 101 : 464 9.
38. Wade K, Quinn MA, Hammond I et al. Uterine sarcoma: steroid receptors and response to hormonal therapy. Gynecol Oncol 1990 39 : 364 7.
39. Burke C, Hickey K. Treatment of endometrial stromal sarcoma with a gonadotropin releasing hormone analogue. Obstet Gynecol 2004 104 : 1182 4.
40. Ota S, Shinagawa K, Ueoka H et al. Spontaneous regression of metastatic endometrial stromal sarcoma. Jpn J Clin Oncol 2002 32 : 71 4.
41. Chu MC, Mor G, Lim C et al. Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol 2003 90 : 170 6.